Critical Outcome Technologies (COTQF) Stock Price, News & Analysis

Company Overview

Critical Outcome Technologies Inc. is a Canadian biotechnology company focused on the discovery and development of small-molecule therapeutics for cancer and other serious diseases. The company has used its computer-aided drug design platform, CHEMSAS, to identify and optimize potential drug candidates.

Its principal development program has been COTI-2, an investigational anticancer compound designed to target cancers associated with mutations in the tumor-suppressor protein p53. The program has been studied for potential applications in gynecological cancers and other solid tumors, although it remains an investigational therapy and is not an approved treatment.

Critical Outcome Technologies has historically operated from London, Ontario, Canada, and has focused primarily on advancing internally developed drug candidates through preclinical and early clinical development. Publicly available information about the company’s current operations, leadership and broader commercial activities is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 12/18/2013
• Today: 11/01/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:COTQF
• CIK: N/A
• Web: coti.theyatesnetwork.com
• Phone: (800) 798-8680
• Fax: 519-858-5179
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A